Neurology Clinical Trials Market is expected to expand at a CAGR of 5.5% from 2021 to 2028
Neurology Clinical Trials Industry Overview The global neurology clinical trials market size is expected to reach USD 7.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. This is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and stringent regulatory requirements pertaining to clinical trials. Neurology Clinical Trials Market Segmentation Grand View Research has segmented the global neurology clinical trials market based on phase, study design, indication, and region: Based on the Phase Insights, the market is segmented into Phase I, Phase II, Phase III, Phase IV The phase II clinical trials segment dominated the market for neurology clinical trials and held the largest revenue share of 36.7% in 2020. This ...